纳米医学
纳米技术
合理设计
材料科学
癌症治疗
药物输送
癌症
风险分析(工程)
纳米颗粒
医学
内科学
作者
Qihang Sun,Zhuxian Zhou,Nasha Qiu,Youqing Shen
标识
DOI:10.1002/adma.201606628
摘要
Current cancer nanomedicines can only mitigate adverse effects but fail to enhance therapeutic efficacies of anticancer drugs. Rational design of next‐generation cancer nanomedicines should aim to enhance their therapeutic efficacies. Taking this into account, this review first analyzes the typical cancer‐drug‐delivery process of an intravenously administered nanomedicine and concludes that the delivery involves a five‐step CAPIR cascade and that high efficiency at every step is critical to guarantee high overall therapeutic efficiency. Further analysis shows that the nanoproperties needed in each step for a nanomedicine to maximize its efficiency are different and even opposing in different steps, particularly what the authors call the PEG, surface‐charge, size and stability dilemmas. To resolve those dilemmas in order to integrate all needed nanoproperties into one nanomedicine, stability, surface and size nanoproperty transitions (3S transitions for short) are proposed and the reported strategies to realize these transitions are comprehensively summarized. Examples of nanomedicines capable of the 3S transitions are discussed, as are future research directions to design high‐performance cancer nanomedicines and their clinical translations.
科研通智能强力驱动
Strongly Powered by AbleSci AI